[Second line treatment regimen of PPI + AMPC + MNZ for patients with clarithromycin-resistant Helicobacter pylori infection]

Nihon Rinsho. 2002 Feb:60 Suppl 2:445-8.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Amoxicillin / administration & dosage*
  • Benzimidazoles / administration & dosage*
  • Clarithromycin
  • Clinical Trials as Topic
  • Drug Administration Schedule
  • Drug Resistance, Bacterial
  • Drug Therapy, Combination
  • Enzyme Inhibitors / administration & dosage*
  • Helicobacter Infections / drug therapy*
  • Helicobacter pylori*
  • Humans
  • Metronidazole / administration & dosage*
  • Omeprazole / administration & dosage*
  • Proton Pump Inhibitors*
  • Rabeprazole
  • Treatment Failure

Substances

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Benzimidazoles
  • Enzyme Inhibitors
  • Proton Pump Inhibitors
  • Metronidazole
  • Rabeprazole
  • Amoxicillin
  • Clarithromycin
  • Omeprazole